Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570544 · ClinicalTrials.gov registry record
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
A clinical trial, sponsored by Gelb, Arthur F., M.D..
- Completed
- Registry status
- 29
- Enrollment target
NCT00570544: Completed study, sponsored by Gelb, Arthur F., M.D..
NCT00570544 is a clinical trial that has completed, run by Gelb, Arthur F., M.D.. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00570544 has completed, sponsored by Gelb, Arthur F., M.D..
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
To evaluate if tiotropium (Spiriva)induced bronchodilation of inspiratory capacity in patients with moderate to severe copd subjected to metronome paced hyperventilation induced dynamic hyperinflation is dependent upon the extent of underlying emphysema as determined by high resolution-thin section CT lung.
Interventions
- DRUG tiotropium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-08 |
What the finished NCT00570544 record still lists
NCT00570544 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which tiotropium is the first listed.
NCT00570544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00570544 about?
NCT00570544 is a clinical study titled "Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema". To evaluate if tiotropium (Spiriva)induced bronchodilation of inspiratory capacity in patients with moderate to severe copd subjected to metronome paced hyperventilation induced dynamic hyperinflation is dependent upon the extent of underlying emphysema as determined by high resolution-thin section ...
What is the current status of trial NCT00570544?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2004-08. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00570544?
The interventions under investigation include: tiotropium (DRUG).
Who is sponsoring clinical trial NCT00570544?
This trial is sponsored by Gelb, Arthur F., M.D., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia